Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cox, Martin J.
2002.
A laboratory-based introduction to seroepidemiology and its use in vaccination programme design.
Journal of Biological Education,
Vol. 36,
Issue. 3,
p.
138.
Muller, Claude P.
and
Mulders, Mick. N.
2002.
The Molecular Epidemiology of Human Viruses.
p.
237.
Nardone, A
Gay, NJ
and
Edmunds, WJ
2002.
Congenital rubella: down but not out.
The Lancet,
Vol. 360,
Issue. 9335,
p.
804.
Mutapi, Francisca
and
Roddam, Andrew
2002.
p values for pathogens: statistical inference from infectious-disease data.
The Lancet Infectious Diseases,
Vol. 2,
Issue. 4,
p.
219.
Bonanni, Paolo
Beutels, P.
Bechini, A.
and
Maci, M.
2003.
Valutazione economica dell’incremento della copertura vaccinale contro la pertosse in Toscana: una nota preliminare.
PharmacoEconomics Italian Research Articles,
Vol. 5,
Issue. S1,
p.
1.
Williams, John R
Manfredi, Piero
Butler, Alisa R
Ciofi degli Atti, Marta
and
Salmaso, Stefania
2003.
Heterogeneity in regional notification patterns and its impact on aggregate national case notification data: the example of measles in Italy.
BMC Public Health,
Vol. 3,
Issue. 1,
Amaku, M.
Coutinho, F. A. B.
Azevedo, R. S.
Burattini, M. N.
Lopez, L. F.
and
Massad, E.
2003.
Vaccination against rubella: Analysis of the temporal evolution of the age-dependent force of infection and the effects of different contact patterns.
Physical Review E,
Vol. 67,
Issue. 5,
Stein, Claudia E.
Birmingham, Maureen
Kurian, Mary
Duclos, Philippe
and
Strebel, Peter
2003.
The Global Burden of Measles in the Year 2000—A Model that Uses Country‐Specific Indicators.
The Journal of Infectious Diseases,
Vol. 187,
Issue. s1,
p.
S8.
MILLER, ELIZABETH
2003.
The Vaccine Book.
p.
37.
Vynnycky, E.
Gay, N.J.
and
Cutts, F.T.
2003.
The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome.
Vaccine,
Vol. 21,
Issue. 21-22,
p.
2708.
Zotti, Carla Maria
Castella, A.
Charrier, L.
De Donno, A.
Lopalco, P. L.
and
Gabutti, G.
2003.
Valutazione economica della vaccinazione antimorbillo-parotite-rosolia in relazione al livello di copertura.
PharmacoEconomics Italian Research Articles,
Vol. 5,
Issue. S1,
p.
65.
Whitaker, H. J.
and
Farrington, C. P.
2004.
Estimation of infectious disease parameters from serological survey data: the impact of regular epidemics.
Statistics in Medicine,
Vol. 23,
Issue. 15,
p.
2429.
Scott, Susana
Mossong, Joel
Moss, William J.
Cutts, Felicity T.
Kasolo, Francis
Sinkala, Moses
and
Cousens, Simon
2004.
Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia.
Vaccine,
Vol. 23,
Issue. 6,
p.
732.
Hethcote, Herbert W
Horby, Peter
and
McIntyre, Peter
2004.
Using computer simulations to compare pertussis vaccination strategies in Australia.
Vaccine,
Vol. 22,
Issue. 17-18,
p.
2181.
Manfredi, Piero
and
Williams, John R.
2004.
Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases.
Mathematical Biosciences,
Vol. 192,
Issue. 2,
p.
153.
Garrido Álvarez, E.
Álvarez Pasquín, M.J.
Gómez Marco, J.
Martín Martín, S.
Kloppe Villegas, P.
and
Hernando López, T.
2004.
Seroprevalencia de anticuerpos antirrubéola en mujeres inmigrantes en edad fértil en 2 centros de salud de Madrid.
Vacunas,
Vol. 5,
Issue. 4,
p.
75.
Tan, H.F
Tseng, H.F
Chang, C.K
Ke, D
and
Lee-Hsieh, J
2004.
The incidence of varicella in southern Taiwan: a life table method estimation among susceptible population.
Vaccine,
Vol. 22,
Issue. 21-22,
p.
2730.
Boubaker, S.Haddad
Ben Yahia, A
Bahri, O
and
Triki, H
2004.
Étude de l’infection par le virus de la rubéole chez l’enfant et l’adolescent en Tunisie.
Pathologie Biologie,
Vol. 52,
Issue. 1,
p.
11.
Van Rie, Annelies
and
Hethcote, Herbert W
2004.
Adolescent and adult pertussis vaccination: computer simulations of five new strategies.
Vaccine,
Vol. 22,
Issue. 23-24,
p.
3154.
Harding, Karin C.
L. Hansen, B. Johan
and
Goodman, Simon J.
2005.
Acquired Immunity and Stochasticity in Epidemic Intervals Impede the Evolution of Host Disease Resistance.
The American Naturalist,
Vol. 166,
Issue. 6,
p.
722.